Filings under STTK by Streamtrack, Inc. (CIK 0001442376) from Apr 30, 2015 to Apr 30, 2015 belong to a different issuer and are not shown. Filings under STTK by Smart-tek Solutions Inc (CIK 0000947011) from Jun 23, 2008 to Jun 23, 2008 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 12K | $3.57 | $43K |
| Jul 6, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 12K | — | $0 |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 410 | $3.57 | $1K |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 410 | $7.01 | $3K |
| Jul 2, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 410 | — | $0 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 100 | $3.57 | $357 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 100 | $7.07 | $707 |
| Jul 1, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 100 | — | $0 |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 23K | $3.57 | $83K |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 23K | $7.08 | $165K |
| Jun 30, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 23K | — | $0 |
| Jun 30, 2026 | Pandite Arundathy N. | Chief Medical Officer | Sell(S) | 30K | $7.01 | $210K |
| Jun 11, 2026 | Ashiya Mona | Director | Buy(P) | 1.0M | — | — |
| Jun 11, 2026 | Ashiya Mona | Director | Buy(P) | 208K | — | — |
| Jun 11, 2026 | Orbimed Advisors LLC | Director | Buy(P) | 1.0M | — | — |
| Jun 11, 2026 | Orbimed Advisors LLC | Director | Buy(P) | 208K | — | — |
| Jun 9, 2026 | Siegall Clay B | Director | Buy(P) | 63K | $4.00 | $250K |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 3.1M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 15.4M | — | — |
| Jun 8, 2026 | Ashiya Mona | Director | Conversion(C) | 3.1M | — | — |
| May 29, 2026 | Baker Daniel G. | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Golumbeski George | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Gibson Neil W | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Ashiya Mona | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Siegall Clay B | Director | Grant(A) | 81K | — | $0 |
| May 29, 2026 | Boudreau Helen M | Director | Grant(A) | 81K | — | $0 |
| May 22, 2026 | Siegall Clay B | Director | Grant(A) | 128K | $1.08 | $139K |
| May 22, 2026 | Siegall Clay B | Director | Option exercise(M) | 128K | — | — |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | $1.08 | $6K |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 5K | — | — |
| May 15, 2026 | Stout Stephen | See Remarks | Grant(A) | 13K | $1.08 | $14K |
| May 15, 2026 | Stout Stephen | See Remarks | Option exercise(M) | 13K | — | — |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | $1.08 | $28K |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Option exercise(M) | 26K | — | — |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | $1.08 | $69K |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | Option exercise(M) | 64K | — | — |
| May 12, 2026 | Pandite Arundathy N. | Chief Medical Officer | Sell(S) | 30K | $6.61 | $198K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 2K | $3.57 | $7K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Sell(S) | 2K | $7.01 | $14K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | Option exercise(M) | 2K | — | $0 |
| May 10, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 968 | $6.85 | $7K |
| Jan 25, 2026 | Neill Andrew R | Chief Financial Officer | Tax withholding(F) | 3K | $4.15 | $11K |
| Jan 25, 2026 | DeYoung Casi | Chief Business Officer | Tax withholding(F) | 2K | $4.15 | $9K |
| Jan 25, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 593 | $4.15 | $2K |
| Jan 25, 2026 | Pandite Arundathy N. | Chief Medical Officer | Tax withholding(F) | 3K | $4.15 | $13K |
| Jan 10, 2026 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 1.5M | — | $0 |
| Jan 10, 2026 | Neill Andrew R | Chief Financial Officer | Tax withholding(F) | 7K | $4.75 | $32K |
| Jan 10, 2026 | Neill Andrew R | Chief Financial Officer | Grant(A) | 550K | — | $0 |
| Jan 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | Tax withholding(F) | 7K | $4.75 | $33K |
| Jan 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | Grant(A) | 488K | — | $0 |
| Jan 10, 2026 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 316K | — | $0 |
| Jan 10, 2026 | DeYoung Casi | Chief Business Officer | Tax withholding(F) | 6K | $4.75 | $27K |
| Jan 10, 2026 | DeYoung Casi | Chief Business Officer | Grant(A) | 382K | — | $0 |
| Jan 10, 2026 | Stout Stephen | See Remarks | Tax withholding(F) | 4K | $4.75 | $20K |
| Jan 10, 2026 | Stout Stephen | See Remarks | Grant(A) | 351K | — | $0 |
| Aug 28, 2025 | Baker Daniel G. | Director | Grant(A) | 66K | — | $0 |
| Aug 28, 2025 | Ashiya Mona | Director | Grant(A) | 66K | — | $0 |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 1.1M | $0.87 | $914K |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 5.3M | $0.87 | $4.6M |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 2.0M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 15.4M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 3.1M | — | — |
| Aug 25, 2025 | Ashiya Mona | Director | Buy(P) | 10.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 5.3M | $0.87 | $4.6M |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 1.1M | $0.87 | $914K |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 2.0M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 10.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 3.1M | — | — |
| Aug 25, 2025 | OrbiMed Capital GP IX LLC | Director | Buy(P) | 15.4M | — | — |
| Aug 25, 2025 | Green Jeremy | Director, 10% Owner | Grant(A) | 4.1M | — | — |
| Aug 25, 2025 | Green Jeremy | Director, 10% Owner | Grant(A) | 4.1M | — | — |
| Aug 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | $0.87 | $4K |
| Aug 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | Grant(A) | 5K | — | — |
| Aug 25, 2025 | Siegall Clay B | Director | Grant(A) | 128K | $0.87 | $111K |
| Aug 25, 2025 | Siegall Clay B | Director | Grant(A) | 128K | — | — |
| Aug 25, 2025 | Stout Stephen | See Remarks | Grant(A) | 13K | $0.87 | $11K |
| Aug 25, 2025 | Stout Stephen | See Remarks | Grant(A) | 13K | — | — |
| Aug 25, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | $0.87 | $22K |
| Aug 25, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 26K | — | — |
| Aug 25, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | $0.87 | $56K |
| Aug 25, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 64K | — | — |
| Jul 14, 2025 | Boudreau Helen M | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Brous Tyler | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Brownstein Carrie | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Gibson Neil W | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Golumbeski George | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Sasser Amy Kate | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Siegall Clay B | Director | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Redmile Group, LLC | Director, 10% Owner | Grant(A) | 33K | — | $0 |
| Jul 14, 2025 | Lee Michael Stewart | Director | Grant(A) | 33K | — | $0 |
| Jan 28, 2025 | Schreiber Taylor | Chief Executive Officer, Director | Grant(A) | 685K | — | $0 |
| Jan 28, 2025 | Neill Andrew R | Chief Financial Officer | Grant(A) | 214K | — | $0 |
| Jan 28, 2025 | Stout Stephen | See Remarks | Grant(A) | 177K | — | $0 |
| Jan 28, 2025 | Pandite Arundathy N. | Chief Medical Officer | Grant(A) | 206K | — | $0 |
| Jan 28, 2025 | DeYoung Casi | Chief Business Officer | Grant(A) | 194K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Shattuck Labs, Inc., SEC CIK 0001680367. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under STTK and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for STTK